Form D · Biotechnology
NEURONA THERAPEUTICS, INC
South San Francisco, CA · CIK 0001443321
Offering snapshot reported Apr 4, 2025 · SEC filing
- Reported sold
- $102M Offering amount: $102M
- Investors reported
- 46 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 28, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 4, 2025 | Initial | $101,711,423 | No comparison | 46 | SEC filing |
| Feb 13, 2024 | Initial | $119,999,974 | No comparison | 35 | SEC filing |
| Dec 23, 2022 | Amendment | $72,008,582 | $43,679,971vs Mar 29, 2021 | 21 | SEC filing |
| Mar 29, 2021 | Initial | $28,328,611 | No comparison | 14 | SEC filing |
| Nov 25, 2019 | Initial | $15,030,288 | No comparison | 9 | SEC filing |
| Feb 27, 2018 | Initial | $10,044,329 | No comparison | 6 | SEC filing |
| Dec 28, 2016 | Amendment | $28,680,743 | $21,036,404vs Dec 23, 2014 | 13 | SEC filing |
| Dec 23, 2014 | Initial | $7,644,339 | No comparison | 11 | SEC filing |
| Aug 15, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-543006
Source: Form D, filed Apr 4, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Goeddel | Director |
| Leo Guthart | Director |
| Stephen Hauser | Director |
| Ray Kelleher | Director |
| Arnold Kriegstein | Director |
| Tim Kutzkey | Director |
| Brad Margus | Director |
| Cory Nicholas | Director, Executive, Promoter |
| James Stutz | Executive |
| Peter Svennilson | Director |
| Robert Tijan | Director |
| Robert Tjian | Director |
| Erica Whitaker | Director |
| Erica Whittaker | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
170 Harbor Way
South San Francisco, CA, 94080
South San Francisco, CA, 94080